A recent Econtalk podcast was with a founder of Give Directly. The idea of this is beautifully simple: money you give to the charity ends up directly in the hands of a very poor person. There are no NGOs involved. No goverment officials are …
read moreThere are comments.
It seems to me that the PBoC is pulling out all the stops to avert a crisis of confidence as Evergrande continues to sink. This should result in the RMB/CNH falling, just as all prices will rise with an increase in the money supply …
read moreThere are comments.
Markets retraced today. Risk assets bounced, bonds sagged (a little bit). Crypto stopped falling. No obvious course. Pundits claim it’s the ‘realization’ that Omicron is not very virulent, but we knew that as soon as it was announced. I guess it’s the bull …
read moreThere are comments.
If you search for “A successful speculator’s approach to commodities trading” by Morris Markovitz, you’ll probably find a pdf of a scan of this book. The whole book is worth reading, but I thought I’d transcribe the …
read moreThere are comments.
Milton Friedman was a formidable economist, and person. I have admired him for most of my adult life. But when it comes to the Fed causing the Great Recession, I think Friedman was wrong. The idea was that the Fed allowed the money …
read moreThere are comments.
Docusign “puked” today. It was down 32% pre-market. Dr Patel joked about it:
read moreDocusign stock price down 30% after analysts discover that the entire business can be replaced by pen and paper
— Dr. Parik Patel, BA, CFA, ACCA Esq. 💸 (@ParikPatelCFA) December 2, 2021 …
There are comments.
This SA piece confirms my view on Suncor. It is profitable, with a foreward P/E of 11.3, it pays a healthy dividend (5.5%), which is well covered and has had recent strong growth. It claims a breakeven price of $35/barrel …
read moreThere are comments.
This post recaps the guru investors who got it wrong in the mid nineties. Basically, they were warning about bubble valuations five years before the Dot Com crash. Being early is the same as being wrong. In the long run we are all right.
The issue …
read moreThere are comments.
The Parallax View published a 9,933-word report on Oramed Pharmaceuticals (NASDAQ: ORMP on), an oral drug delivery systems company focused on treating diabetes. Parallax highlighted excessive insider compensation including $3.2 million to the company CEO, Nadav Kidron, and his mother, who serves as Chief Scientific Officer …
read moreThere are comments.